收藏 分享(赏)

神经节苷脂治疗后吉兰巴雷综合征PPT课件.pptx

上传人:微传9988 文档编号:3476356 上传时间:2018-11-03 格式:PPTX 页数:19 大小:1.13MB
下载 相关 举报
神经节苷脂治疗后吉兰巴雷综合征PPT课件.pptx_第1页
第1页 / 共19页
神经节苷脂治疗后吉兰巴雷综合征PPT课件.pptx_第2页
第2页 / 共19页
神经节苷脂治疗后吉兰巴雷综合征PPT课件.pptx_第3页
第3页 / 共19页
神经节苷脂治疗后吉兰巴雷综合征PPT课件.pptx_第4页
第4页 / 共19页
神经节苷脂治疗后吉兰巴雷综合征PPT课件.pptx_第5页
第5页 / 共19页
点击查看更多>>
资源描述

1、,Guillain-Barre syndrome (GBS),AIDP AMAN AMSAN MFS,Ganglioside,神经节苷脂广泛分布于全身各组织细胞的外表面,在神经系统中含量丰富,在周围神经系统中主要存在于轴索,而在胶质和髓鞘中浓度较低 根据其糖基结合唾液酸分子的数目及部位分为GM、GD、GT 及GQ,Pathology,AMAN and AMASN are associated with Campylobacter jejuni enteritis and antibodies against gangliosides,chemical structure of ganglios

2、ides,不同种类的神经节苷脂在周围神经系统的分布具有各自不同的特点,GM1除广泛分布于周围神经的轴索,还分布于郎飞氏节及施万细胞近轴索侧细胞膜,在运动神经髓鞘内GM1的含量多于其在感觉神经髓鞘内的含量 GD1b在后根神经节大感觉神经元分布较多 GQ1b在动眼、滑车、外展神经的髓鞘中含量高于其他颅神经,特定抗神经节苷脂抗体和具有某些特异临床特点的神经系统疾病相关,抗GM1抗体见于急性运动轴索性神经病(AMAN)及脱髓鞘性GBS,IgM类GM1抗体见于多灶性运动神经病(MMN),症状学研究提示GM1抗体阳性的患者更多出现肢体无力,而感觉障碍相对较少 抗GD1b抗体与感觉性共济失调等感觉障碍为主的

3、疾病相关 GQ1b与Miller-Fisher 综合征(MFS),Bickerstaff脑干脑炎(BEE)等存在眼肌麻痹或球部肌肉受累的疾病相关,After exogenous gangliosides injection,High titers of anti-GM1 antibodies were found in patients who developed GBS following exogenous gangliosides injection , leading to the suspicion that exogenous gangliosides might be forei

4、gn to humans and may act as an immunogenic agent.,GBS following intravenous use of gangliosides in Europe several decades ago led to its withdrawal from European market,Figueras A, Morales-Olivas FJ, Capella D, Palop V, Laporte JR (1992) Bovine gangliosides and acute motor polyneuropathy. BMJ 305:13

5、301331.,We identified 7 patients who developed GBS after intravenous use of gangliosides,Department of Neurology of the First Hospital of Jilin University 2013 Gangliosides as an exclusive component or part of a compound have never been used in our department and all the enrolled patients were refer

6、red to our department from other departments or from other hospitals.,Grouping,Enrolled subjects were divided into the ganglioside+ group (ganglioside-associated) and the ganglioside- group (non-ganglioside-associated) according to whether they received exogenous gangliosides before disease onset.,E

7、valuation of clinical severity and functional impairment,Motor function deficits of patients were scored by the Hughes Functional Grading Scale(HFGS) score Neurologic function was also evaluated by using the Medical Research Council (MRC) sum score of six bilateral muscles in arms and legs, ranging

8、from 0 (tetraparalytic) to 60 (normal strength),The association between exogenous gangliosides and GBS,high titers of anti-GM1 antibodies were found in some of the patients who developed GBS after receiving a ganglioside therapy, leading to the suspicion that exogenous gangliosides might be foreign

9、to humans and might be neuritogenic in humans The association between exogenous gangliosides and GBS was further evidenced by the positivity of anti-GM1 and anti-GT1a antibodies in CSF and plasma,Sum,In sum, exogenous gangliosides may be associated with development of GBS due to incompletely recognized pathogenesis. Ganglioside-associated GBS is more severe in clinical course with poorer short-term prognosis as compared with non-gangliosideassociated GBS in northeast China.,

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 实用文档 > 教育范文

本站链接:文库   一言   我酷   合作


客服QQ:2549714901微博号:道客多多官方知乎号:道客多多

经营许可证编号: 粤ICP备2021046453号世界地图

道客多多©版权所有2020-2025营业执照举报